Merck KGaA (OTCMKTS:MKGAF) Sees Unusually-High Trading Volume – Time to Buy?

Merck KGaA (OTCMKTS:MKGAF) shares saw unusually-strong trading volume on Tuesday . 686 shares changed hands during trading, an increase of 10% from the previous session’s volume of 621 shares.The stock last traded at $162.55 and had previously closed at $158.25.

Merck KGaA Price Performance

The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The firm has a market cap of $20.95 billion, a price-to-earnings ratio of 24.74 and a beta of 0.96. The stock has a 50-day moving average of $162.24 and a two-hundred day moving average of $148.17.

Institutional Trading of Merck KGaA

Hedge funds and other institutional investors have recently modified their holdings of the company. Frazier Financial Advisors LLC purchased a new position in Merck KGaA in the second quarter valued at about $25,000. Rakuten Securities Inc. acquired a new position in Merck KGaA in the 2nd quarter worth about $27,000. Delos Wealth Advisors LLC purchased a new stake in shares of Merck KGaA during the 2nd quarter worth about $33,000. Solstein Capital LLC purchased a new stake in shares of Merck KGaA during the 2nd quarter worth about $33,000. Finally, Burk Holdings LLC acquired a new stake in shares of Merck KGaA during the 2nd quarter valued at about $39,000. 0.10% of the stock is currently owned by hedge funds and other institutional investors.

About Merck KGaA

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.